David J. Caponera
Corporate Officer/Principal presso DICERNA PHARMACEUTICALS, INC.
Profilo
David J.
Caponera is currently the Head of Patient Advocacy and Patient Services at Dicerna Pharmaceuticals, Inc. Previously, he worked as the VP of Patient Engagement and Access Support at Catalyst Pharmaceuticals, Inc. from 2014 to 2018.
He received his graduate degree from Duke University and his undergraduate degree from Cornell University.
Posizioni attive di David J. Caponera
| Società | Posizione | Inizio |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13/06/2019 |
Precedenti posizioni note di David J. Caponera
| Società | Posizione | Fine |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2018 |
Formazione di David J. Caponera
| Duke University | Graduate Degree |
| Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- David J. Caponera
